Cargando…

CONSORT-Characteristics and metabolic phenotype of gut microbiota in NAFLD patients

Patients with nonalcoholic fatty liver disease (NAFLD) have symptoms of a gut microbiota disorder with abnormal amino acid and glycolipid metabolism. This study was designed to analyze the characteristics of gut microbiota in patients with NAFLD, predict the gut microbiota phenotype, explore its rol...

Descripción completa

Detalles Bibliográficos
Autores principales: Ge, Haize, Wei, Wei, Tang, Liang, Tian, Yaqiong, Zhu, Yu, Luo, Yan, Liu, Shuye
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9276074/
https://www.ncbi.nlm.nih.gov/pubmed/35758365
http://dx.doi.org/10.1097/MD.0000000000029347
_version_ 1784745634744500224
author Ge, Haize
Wei, Wei
Tang, Liang
Tian, Yaqiong
Zhu, Yu
Luo, Yan
Liu, Shuye
author_facet Ge, Haize
Wei, Wei
Tang, Liang
Tian, Yaqiong
Zhu, Yu
Luo, Yan
Liu, Shuye
author_sort Ge, Haize
collection PubMed
description Patients with nonalcoholic fatty liver disease (NAFLD) have symptoms of a gut microbiota disorder with abnormal amino acid and glycolipid metabolism. This study was designed to analyze the characteristics of gut microbiota in patients with NAFLD, predict the gut microbiota phenotype, explore its role in the diagnosis of NAFLD, and establish its significance in disease progression. The characteristics of the gut microbiota in NAFLD patients (n = 28, 45.8 ± 14.2 years, male/female = 18/10) and healthy subjects (n = 20, 49.6 ± 4.8 years, male/female = 14/6) during March–May 2020 were analyzed using 16S rRNA sequencing technology and the phenotypes with large differences were predicted using the Tax4Fun method. The metabolites in the fecal samples of the patients were analyzed using mass spectrometry, and their correlation with different microorganisms was examined. The accuracy of the gut microbiota in diagnosing NAFLD was investigated by receiver operating characteristic curve analysis. We found that the microbial diversity and Bacteroides/Firmicutes (BF) ratio changed significantly (P < .05) in the feces of NAFLD patients. Phenotypic prediction showed that there were significant differences in the phenotypes of amino acid, glucose, and lipid metabolism of gut microbiota in the NAFLD group (P < .05). receiver operating characteristic curve analysis revealed that combination of Bacteroides and the BF ratio resulted in 88% and 100% sensitivity and specificity, respectively, when used for NAFLD diagnosis. Metabolomics and bioinformatics analysis revealed changes in the metabolism of nicotinate, nicotinamide, and pyrimidine; signaling pathways of calcium and oxytocin; pancreatic secretion with metabolites such as uracil, xanthine, and biliverdin; and enzymes such as xanthine dehydrogenase and xanthine oxidase (P < .05). Therefore, the phenotypic changes may be a potential marker for NAFLD and we considered that a combined analysis of Bacteroides and BF ratio had good diagnostic accuracy for NAFLD.
format Online
Article
Text
id pubmed-9276074
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-92760742022-07-13 CONSORT-Characteristics and metabolic phenotype of gut microbiota in NAFLD patients Ge, Haize Wei, Wei Tang, Liang Tian, Yaqiong Zhu, Yu Luo, Yan Liu, Shuye Medicine (Baltimore) 4500 Patients with nonalcoholic fatty liver disease (NAFLD) have symptoms of a gut microbiota disorder with abnormal amino acid and glycolipid metabolism. This study was designed to analyze the characteristics of gut microbiota in patients with NAFLD, predict the gut microbiota phenotype, explore its role in the diagnosis of NAFLD, and establish its significance in disease progression. The characteristics of the gut microbiota in NAFLD patients (n = 28, 45.8 ± 14.2 years, male/female = 18/10) and healthy subjects (n = 20, 49.6 ± 4.8 years, male/female = 14/6) during March–May 2020 were analyzed using 16S rRNA sequencing technology and the phenotypes with large differences were predicted using the Tax4Fun method. The metabolites in the fecal samples of the patients were analyzed using mass spectrometry, and their correlation with different microorganisms was examined. The accuracy of the gut microbiota in diagnosing NAFLD was investigated by receiver operating characteristic curve analysis. We found that the microbial diversity and Bacteroides/Firmicutes (BF) ratio changed significantly (P < .05) in the feces of NAFLD patients. Phenotypic prediction showed that there were significant differences in the phenotypes of amino acid, glucose, and lipid metabolism of gut microbiota in the NAFLD group (P < .05). receiver operating characteristic curve analysis revealed that combination of Bacteroides and the BF ratio resulted in 88% and 100% sensitivity and specificity, respectively, when used for NAFLD diagnosis. Metabolomics and bioinformatics analysis revealed changes in the metabolism of nicotinate, nicotinamide, and pyrimidine; signaling pathways of calcium and oxytocin; pancreatic secretion with metabolites such as uracil, xanthine, and biliverdin; and enzymes such as xanthine dehydrogenase and xanthine oxidase (P < .05). Therefore, the phenotypic changes may be a potential marker for NAFLD and we considered that a combined analysis of Bacteroides and BF ratio had good diagnostic accuracy for NAFLD. Lippincott Williams & Wilkins 2022-06-24 /pmc/articles/PMC9276074/ /pubmed/35758365 http://dx.doi.org/10.1097/MD.0000000000029347 Text en Copyright © 2022 the Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0 (https://creativecommons.org/licenses/by/4.0/)
spellingShingle 4500
Ge, Haize
Wei, Wei
Tang, Liang
Tian, Yaqiong
Zhu, Yu
Luo, Yan
Liu, Shuye
CONSORT-Characteristics and metabolic phenotype of gut microbiota in NAFLD patients
title CONSORT-Characteristics and metabolic phenotype of gut microbiota in NAFLD patients
title_full CONSORT-Characteristics and metabolic phenotype of gut microbiota in NAFLD patients
title_fullStr CONSORT-Characteristics and metabolic phenotype of gut microbiota in NAFLD patients
title_full_unstemmed CONSORT-Characteristics and metabolic phenotype of gut microbiota in NAFLD patients
title_short CONSORT-Characteristics and metabolic phenotype of gut microbiota in NAFLD patients
title_sort consort-characteristics and metabolic phenotype of gut microbiota in nafld patients
topic 4500
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9276074/
https://www.ncbi.nlm.nih.gov/pubmed/35758365
http://dx.doi.org/10.1097/MD.0000000000029347
work_keys_str_mv AT gehaize consortcharacteristicsandmetabolicphenotypeofgutmicrobiotainnafldpatients
AT weiwei consortcharacteristicsandmetabolicphenotypeofgutmicrobiotainnafldpatients
AT tangliang consortcharacteristicsandmetabolicphenotypeofgutmicrobiotainnafldpatients
AT tianyaqiong consortcharacteristicsandmetabolicphenotypeofgutmicrobiotainnafldpatients
AT zhuyu consortcharacteristicsandmetabolicphenotypeofgutmicrobiotainnafldpatients
AT luoyan consortcharacteristicsandmetabolicphenotypeofgutmicrobiotainnafldpatients
AT liushuye consortcharacteristicsandmetabolicphenotypeofgutmicrobiotainnafldpatients